InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Grant-Huerta Yanina. Insider active across 3 companies, notably Atara Biotherapeutics, Inc.. Cumulatively, 7 disclosures have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €33k. Activity tracked since 16 May 2025. The latest transaction was filed on 14 August 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Grant-Huerta Yanina is a declarant linked to Atara Biotherapeutics, Inc. as Chief Accounting Officer and to ImageneBio, Inc. as Chief Financial Officer. She has 7 filings in total, and among the sampled recent filings from 2025-05-20 to 2026-08-17, the reported sell amount is 32727 EUR, with the dominant transaction nature indicated as Cession.